Lista de obras - Stefano Fagiuoli - Dominio Público Uruguay

A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients

artículo científico publicado en 2020

A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list

artículo científico publicado en 2013

A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma

artículo científico publicado en 2013

Adaptations and Lessons in the Province of Bergamo

scientific article published on 05 May 2020

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

artículo científico publicado en 2021

Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features

artículo científico publicado el 1 de marzo de 1992

Antibiotic stewardship and empirical antibiotic treatment: How can they get along?

artículo científico publicado en 2017

Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study.

artículo científico publicado en 2012

At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy

scientific article published on 27 November 2020

Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology

scientific article published on 12 November 2019

Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases

artículo científico publicado en 2012

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

artículo científico publicado en 2020

Consensus conference on TIPS management: Techniques, indications, contraindications

artículo científico publicado en 2016

Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients

scientific article published on 09 June 2020

Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation

artículo científico publicado en 2015

Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease ⬇️

artículo científico publicado el 1 de abril de 1995

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

artículo científico publicado en 2019

Delisting HCV infected Liver Transplant Candidates who improved after Viral Eradication: Outcome 2 Years after Delisting.

artículo científico publicado en 2018

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

artículo científico publicado en 2016

Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice

artículo científico publicado en 2011

Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins.

artículo científico publicado en 2006

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

artículo científico publicado en 2009

ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.

artículo científico publicado en 2017

Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir

scientific article published on 07 January 2019

Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C.

artículo científico publicado en 2016

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study

artículo científico publicado en 2017

Emerging biological agents for hepatitis C.

artículo científico publicado en 2016

Endogenous interferon-alpha level is increased in hepatitis C virus (HCV)-positive pregnant women

artículo científico publicado en 2008

Gut microbiota in autism and mood disorders

artículo científico publicado en 2016

HLA-DRB1 Donor-Recipient Mismatch Affects the Outcome of Hepatitis C Disease Recurrence After Liver Transplantation

artículo científico publicado en 2006

Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy

scientific article published on 12 May 2020

HepaDisk - A new quality of life questionnaire for HCV patients

artículo científico publicado en 2018

Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis.

artículo científico

Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study

artículo científico publicado en 2012

Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse

artículo científico publicado en 2005

Hepatitis C virus and liver transplantation: where do we stand?

artículo científico

High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

scientific article published on 11 December 2020

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries

artículo científico publicado en 2015

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients

scientific article published on 27 October 2020

Infections and Organ Transplantation

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

artículo científico publicado en 2013

International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.

artículo científico publicado en 2017

International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates

artículo científico publicado en 2017

International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients

Is rejection a diffuse or localized process in small-bowel transplantation?

artículo científico publicado en 1994

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching

artículo científico publicado en 2010

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

artículo científico publicado en 2007

Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders

artículo científico publicado en 2005

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

artículo científico publicado en 2004

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

artículo científico publicado en 2018

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.

artículo científico publicado en 2014

Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper

artículo científico publicado en 2019

Management of hepatitis C infection before and after liver transplantation

artículo científico publicado en 2015

Management of infections in cirrhotic patients: report of a consensus conference

artículo científico publicado en 2013

Management of infections pre- and post-liver transplantation: report of an AISF consensus conference

artículo científico publicado en 2013

Managing hepatitis C virus-HIV liver transplant recipients with the new direct-acting antivirals: are we glimpsing a brilliant future behind our shoulders?

artículo científico publicado en 2016

MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.

artículo científico publicado en 2014

Monogenic diseases that can be cured by liver transplantation

artículo científico publicado en 2013

Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients

artículo científico publicado en 2003

Obliterative portal venopathy without portal hypertension: an underestimated condition.

artículo científico publicado en 2015

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

artículo científico publicado en 2020

Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis.

artículo científico

Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine.

artículo científico publicado en 2017

Outcomes of Liver Transplant for Adults With Wilson's Disease

artículo científico publicado en 2020

Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.

artículo científico publicado en 2005

Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation

artículo científico publicado en 2015

Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort

artículo científico publicado en 2018

Prophylaxis of spontaneous bacterial peritonitis: Is there still room for quinolones?

scientific article published on 02 February 2019

Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma

artículo científico publicado el 1 de mayo de 1992

Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease

artículo científico publicado en 2006

Real life experiences in HCV management in 2018

artículo científico publicado en 2019

Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in 723 patients with chronic hepatitis C

scientific article published on 23 November 2018

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

artículo científico publicado en 2019

Refining sorafenib therapy: lessons from clinical practice.

artículo científico

Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features

artículo científico publicado en 2007

Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study

scientific article published on 06 December 2019

Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C.

artículo científico publicado en 2009

Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF).

artículo científico publicado en 2013

Small hepatocellular carcinomas and thrombocytopenia

artículo científico publicado en 2012

Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study

artículo científico publicado en 2017

Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis: a retrospective study

artículo científico publicado en 2007

The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience

artículo científico publicado en 2017

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

artículo científico publicado en 2004

The societal burden of chronic liver diseases: results from the COME study.

artículo científico publicado en 2015

The use of granulocyte-macrophage colony-stimulating factor to enhance hematologic parameters of patients with cirrhosis and hypersplenism.

artículo científico publicado en 1994

Treatment of genotype-1 hepatitis C recurrence after liver transplant improves survival in both sustained responders and relapsers

artículo científico publicado en 2012

Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients

artículo científico publicado en 2012

Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study

artículo científico publicado en 2012

Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis.

artículo científico publicado en 2018

Use of Everolimus in Liver Transplantation: Recommendations From a Working Group.

artículo científico publicado en 2017

Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.

artículo científico publicado en 2016

Value of HCC-MELD Score in Patients With Hepatocellular Carcinoma Undergoing Liver Transplantation

artículo científico publicado en 2017

What can we learn about biofilm/host interactions from the study of inflammatory bowel disease

artículo científico publicado en 2011

Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?

artículo científico publicado en 2011

Lista de obras de Stefano Fagiuoli

A Very Short Course of HBIg+NA Followed by Entecavir or Tenofovir Monotherapy Prevents HBV Recurrence in Low-Risk Liver Transplant Recipients

A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list

A phase II randomized dose escalation trial of sorafenib in patients with advanced hepatocellular carcinoma

Adaptations and Lessons in the Province of Bergamo

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical features

Antibiotic stewardship and empirical antibiotic treatment: How can they get along?

Antiviral therapy and fibrosis progression in patients with mild-moderate hepatitis C recurrence after liver transplantation. A randomized controlled study.

At the peak of Covid-19 age and disease severity but not comorbidities are predictors of mortality. Covid-19 burden in Bergamo, Italy

Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology

Comparing the performance of the standard EQ-5D 3L with the new version EQ-5D 5L in patients with chronic hepatic diseases

Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort

Consensus conference on TIPS management: Techniques, indications, contraindications

Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients

Cost-effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation

Cryoglobulinemia: a cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease ⬇️

Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program

Delisting HCV infected Liver Transplant Candidates who improved after Viral Eradication: Outcome 2 Years after Delisting.

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study

Diagnosis, treatment and survival of patients with hepatorenal syndrome: A survey on daily medical practice

Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins.

Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.

ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.

Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir

Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C.

Efficacy, safety, and pharmacokinetics of simeprevir, daclatasvir, and ribavirin in patients with recurrent hepatitis C virus genotype 1b infection after orthotopic liver transplantation: The Phase II SATURN study

Emerging biological agents for hepatitis C.

Endogenous interferon-alpha level is increased in hepatitis C virus (HCV)-positive pregnant women

Gut microbiota in autism and mood disorders

HLA-DRB1 Donor-Recipient Mismatch Affects the Outcome of Hepatitis C Disease Recurrence After Liver Transplantation

Health status of patients with Autoimmune Liver Disease during SARS-CoV-2 outbreak in northern Italy

HepaDisk - A new quality of life questionnaire for HCV patients

Hepatitis B in immunosuppressed cancer patients: pathogenesis, incidence and prophylaxis.

Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the Liver Match cohort study

Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse

Hepatitis C virus and liver transplantation: where do we stand?

High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries

Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients

Infections and Organ Transplantation

Interaction between calcineurin inhibitors and IL-28B rs12979860 C>T polymorphism and response to treatment for post-transplant recurrent hepatitis C.

International Liver Transplant Society Consensus Statement on HEPATITIS C MANAGEMENT IN LIVER TRANSPLANT RECIPIENTS.

International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Candidates

International Liver Transplantation Society Consensus Statement on Hepatitis C Management in Liver Transplant Recipients

Is rejection a diffuse or localized process in small-bowel transplantation?

Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching

Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study.

Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial

Long-term maintenance of sustained virological response in liver transplant recipients treated for recurrent hepatitis C.

Management of adverse events associated with idelalisib treatment in chronic lymphocytic leukemia and follicular lymphoma: A multidisciplinary position paper

Management of hepatitis C infection before and after liver transplantation

Management of infections in cirrhotic patients: report of a consensus conference

Management of infections pre- and post-liver transplantation: report of an AISF consensus conference

Managing hepatitis C virus-HIV liver transplant recipients with the new direct-acting antivirals: are we glimpsing a brilliant future behind our shoulders?

MicroRNA-425-3p predicts response to sorafenib therapy in patients with hepatocellular carcinoma.

Monogenic diseases that can be cured by liver transplantation

Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients

Obliterative portal venopathy without portal hypertension: an underestimated condition.

On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites

Open versus laparoscopic cholecystectomy in acute cholecystitis. Systematic review and meta-analysis.

Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine.

Outcomes of Liver Transplant for Adults With Wilson's Disease

Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: Assessment of efficacy at explant analysis and of safety for tumor recurrence.

Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation

Prevalent use of combined prophylaxis of hepatitis B after liver transplantation in Italy: results of a national survey in a large cohort

Prophylaxis of spontaneous bacterial peritonitis: Is there still room for quinolones?

Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma

Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease

Real life experiences in HCV management in 2018

Real-life effectiveness and safety of Glecaprevir/Pibrentasvir in 723 patients with chronic hepatitis C

Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure

Refining sorafenib therapy: lessons from clinical practice.

Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features

Renal safety in 3264 HCV patients treated with DAA-based regimens: Results from a large Italian real-life study

Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C.

Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF).

Small hepatocellular carcinomas and thrombocytopenia